Bothell based BioLife Solutions, Inc. and HemaCare Corporation, today announced a strategic relationship wherein HemaCare will market BioLife’s HypoThermosol® and CryoStor® biopreservation media products and HemaCare’s blood derived cells to the research and clinical communities.

BioLife is a developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and contract aseptic media manufacturer. HemaCare is a supplier of blood derived cells and components for research and clinical applications.

“HemaCare offers best-in-class bioresearch products derived from the most robust and highest quality apheresis collections,” said BioLife Solutions President and CEO Mike Rice. “We’re glad to partner with them to enable a new product option for their customers. We look forward to additional collaborative research that we believe will generate even more data supporting the value proposition of our proprietary biopreservation media products.”

More information on the agreement can be found here.